Autologous bone marrow- or cardiac-derived stem cell therapy for heart disease has demonstrated safety and efficacy in clinical trials but functional improvements have been limited.
http://circres.ahajournals.org/content/early/2013/06/25/CIRCRESAHA.113.301202.short?rss=1
http://circres.ahajournals.org/content/early/2013/06/25/CIRCRESAHA.113.301202.short?rss=1
No comments:
Post a Comment